Re: Copy of Joe Springer Article - 5 Reasons MannKind Could Be The Best Performing S
|
|
Mannkind
|
Jun 22, 2013 12:29PM
|
Re: David Kuo reflects on market volatility
|
|
Mannkind
|
Jun 25, 2013 09:42AM
|
Re: Trial results
|
2
|
Mannkind
|
Jun 25, 2013 03:50PM
|
Re: Trial results
|
2
|
Mannkind
|
Jun 26, 2013 09:30AM
|
Question Regarding ATM
|
|
Mannkind
|
Jun 27, 2013 10:24PM
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 01, 2013 10:45AM
|
Re: MannKind announces $160M debt financing
|
|
Mannkind
|
Jul 02, 2013 10:43AM
|
Re: A Leading Indicator Of Success: Failure And Risk In Biotechnology
|
2
|
Mannkind
|
Jul 08, 2013 10:05PM
|
Re: Best Defensive Strategy
|
|
Mannkind
|
Jul 09, 2013 09:50AM
|
Re: Anyone listening to the conference?
|
|
Mannkind
|
Jul 10, 2013 11:19AM
|
Re: Best Defensive Strategy/Plankman
|
1
|
Mannkind
|
Jul 11, 2013 01:02PM
|
Re: What do you think will happen if only one study is successful
|
|
Mannkind
|
Jul 12, 2013 10:32AM
|
Re: European submission
|
2
|
Mannkind
|
Jul 17, 2013 01:28PM
|
Re: Could Mannkind go it alone with an unconventional marketing approach?
|
2
|
Mannkind
|
Jul 18, 2013 09:19AM
|
Re: Newbie to Options
|
|
Mannkind
|
Jul 20, 2013 02:00PM
|
Re: Newbie to Options
|
|
Mannkind
|
Jul 20, 2013 04:19PM
|
Exceptional YMB Post
|
5
|
Mannkind
|
Jul 20, 2013 04:27PM
|
Re: Was the 30 milligram study started after
|
2
|
Mannkind
|
Jul 21, 2013 02:28PM
|
Re: [Added] 1500 MNKD @ 7.06 pps
|
1
|
Mannkind
|
Jul 22, 2013 03:14PM
|
Re: MannKind Corporation Implements BioPharm Systems’ Siebel Clinical Trial
|
4
|
Mannkind
|
Jul 23, 2013 10:17AM
|